€3.83
4.64% today
Xetra, Dec 06, 05:36 pm CET
ISIN
DE0005203947
Symbol
BNN
Index
Sector
Industry

BRAIN Biotech Stock price

€3.83
+1.27 49.61% 1M
+1.04 37.28% 6M
+0.17 4.64% YTD
+0.32 9.12% 1Y
-5.27 57.91% 3Y
-5.55 59.17% 5Y
-5.27 57.90% 10Y
Xetra, Closing price Fri, Dec 06 2024
+0.17 4.64%
ISIN
DE0005203947
Symbol
BNN
Index
Sector
Industry

Key metrics

Market capitalization €79.96m
Enterprise Value €108.31m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.96
P/S ratio (TTM) P/S ratio 1.44
P/B ratio (TTM) P/B ratio 4.34
Revenue growth (TTM) Revenue growth 3.66%
Revenue (TTM) Revenue €55.37m
EBIT (operating result TTM) EBIT €-6.44m
Free Cash Flow (TTM) Free Cash Flow €-3.91m
EPS (TTM) EPS €-0.37
P/E forward negative
P/S forward 1.38
EV/Sales forward 1.87
Show more

Is BRAIN Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.

BRAIN Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a BRAIN Biotech forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a BRAIN Biotech forecast:

Buy
100%

Financial data from BRAIN Biotech

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Mar '24
+/-
%
55 55
4% 4%
100%
- Direct Costs 51 51
1% 1%
93%
3.90 3.90
205% 205%
7%
- Selling and Administrative Expenses 5.79 5.79
0% 0%
10%
- Research and Development Expense - -
-
-
-1.66 -1.66
63% 63%
-3%
- Depreciation and Amortization 4.78 4.78
6% 6%
9%
EBIT (Operating Income) EBIT -6.44 -6.44
29% 29%
-12%
Net Profit -8.05 -8.05
8% 8%
-15%

In millions EUR.

Don't miss a Thing! We will send you all news about BRAIN Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BRAIN Biotech Stock News

EQS
about one month ago
Die BRAIN Biotech AG ist ein führender Anbieter von integrierten Lösungen und Produkten der Industriellen Biotechnologie. Das Unternehmen ist spezialisiert auf Enzyme und Proteine, mikrobielle Produktionsstämme und Bioprozesse für biotechnologische Produktionsverfahren. BRAIN Biotech spezialisier...
EQS
about one month ago
Zwingenberg, Deutschland, 31. Oktober 2024 – Die BRAIN Biotech AG (ISIN DE0005203947; „BRAIN“ oder „Gesellschaft“) hat eine exklusive Pharma-Lizenzvereinbarung für die Genom-Editierungsnuklease G-dase E® mit der Akribion Therapeutics GmbH („Akribion“) geschlossen. Im Gegenzug für die Gewährung d...
More BRAIN Biotech News

Company Profile

B.R.A.I.N. Biotechnology Research & Information Network AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Ulrich Putsch, Holger Zinke, Gabriele Sachse, and Hans-Günter Gassen in 1993 and is headquartered in Zwingenberg, Germany.

Head office Germany
CEO Adriaan Moelker
Employees 309
Founded 1993
Website www.brain-biotech.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today